APA
Heo J., Noh B., Lee S., Lee H., Kim Y., Lim J., Ju H., Yu H. Y., Ryu C., Lee P. C., Jeong H., Oh Y., Kim K., Kim S., Son J., Hong B., Kim J. S., Cho Y. M. & Shin D. (20210727). Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis. : EMBO molecular medicine.
Chicago
Heo Jinbeom, Noh Byeong-Joo, Lee Seungun, Lee Hye-Yeon, Kim YongHwan, Lim Jisun, Ju Hyein, Yu Hwan Yeul, Ryu Chae-Min, Lee Peter Cw, Jeong Hwangkyo, Oh Yumi, Kim Kyunggon, Kim Sang-Yeob, Son Jaekyoung, Hong Bumsik, Kim Jong Soo, Cho Yong Mee and Shin Dong-Myung. 20210727. Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis. : EMBO molecular medicine.
Harvard
Heo J., Noh B., Lee S., Lee H., Kim Y., Lim J., Ju H., Yu H. Y., Ryu C., Lee P. C., Jeong H., Oh Y., Kim K., Kim S., Son J., Hong B., Kim J. S., Cho Y. M. and Shin D. (20210727). Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis. : EMBO molecular medicine.
MLA
Heo Jinbeom, Noh Byeong-Joo, Lee Seungun, Lee Hye-Yeon, Kim YongHwan, Lim Jisun, Ju Hyein, Yu Hwan Yeul, Ryu Chae-Min, Lee Peter Cw, Jeong Hwangkyo, Oh Yumi, Kim Kyunggon, Kim Sang-Yeob, Son Jaekyoung, Hong Bumsik, Kim Jong Soo, Cho Yong Mee and Shin Dong-Myung. Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis. : EMBO molecular medicine. 20210727.